Therapeutic Workshop
Sleeping Giant: Opportunities in Sleep Disorders
Thursday, October 20
8:15 a.m. - 9:15 a.m.
Twin Peaks South
Programming sleep and consciousness with new pharmaceuticals agents, and why these products have so many more possibilities than what meets the open (or closed) eye, will be discussed by a panel of experts. New sleep agents, companies in this specialty, and the opportunities that may come from other indications will be reviewed. Gain perspective from a market leader in sleep on lessons in managing product life cycle in this dynamic marketplace. Attendees learned how the emerging players are strategically addressing clinical development, investment decisions and pharmaceutical portfolio management.
Moderator:
- Ken Trbovich, CFA, VP-Specialty Pharmaceutical Analyst, RBC Capital Markets Corporation
Panelists:
- Dominic P. Behan, PhD, Co-Founder, Director, Senior Vice President and Chief Scientific Officer, Arena Pharmaceuticals, Inc.
- Jed E. Black, MD, Medical Director, Sleep Disorders Clinic, Assistant Professor, Stanford University
- Phil Perera, MD Chief Medical Officer, VP Clinical Research and Medical Affairs, Jazz Pharmaceuticals, Inc.
- Srinivas G. Rao, MD, PhD, Chief Scientific Officer, Cypress Bioscience, Inc.
- Martin Tolar, MD, PhD, Director, Licensing & Development, Pfizer, Inc.